Lucid Diligence Brief: Genethon and Ampersand Biomedicines AAV Partnership
Lucid Diligence Brief: Genethon and Ampersand Biomedicines partner to design…
Lucid Diligence Brief: Catalent and Elpida Therapeutics announced a strategic partnership for late-phase AAV manufacturing
Lucid Diligence Brief: Catalent and Elpida Therapeutics announced a strategic…
Lucid Diligence Brief: Apertura Gene Therapy and TSC Alliance Collaboration
Lucid Diligence Brief: Apertura Gene Therapy and TSC Alliance Collaboration…
Lucid Diligence Brief: Latus Bio $97 million Series A
Lucid Diligence Brief: Latus Bio $97 million Series A Professional audiences…
Public Health Today—April 24, 2026
This weekly Public Health update highlights key developments across policy,…
Lucid Diligence Brief: MeiraGTx re-acquires bota-vec rights from J&J
Lucid Diligence Brief: MeiraGTx re-acquires bota-vec rights from J&J…
Neuroscience Today—April 15, 2026
This week’s Neuroscience update highlights regulatory progress, biomarker-based…
Public Health Today—April 3, 2026
This weekly update in public health highlights new evidence across…
Public Health Video Recap—March 13, 2026
Welcome to our biweekly public health video recap, summarizing the latest…
Public Health Today—March 6, 2026
This weekly Public Health update highlights recent research findings,…
Cell and Gene Therapy Today—March 5, 2026
This is a weekly update in gene and cell therapy, covering key regulatory…
Neuroscience Today—March 4, 2026
This week's Neuroscience update covers key developments across late-stage…